2nd annual Faces of Glaucoma campaign unveiled by Bausch + Lomb, Glaucoma Research Foundation

News
Article

The campaign will spotlight educational resources and share stories of individuals and families living with glaucoma to raise awareness and encourage proactive eye health management.

faces of glaucoma campaign kicked off by Bausch + Lomb and The Glaucoma Research Foundation - Image credit: Adobe Stock / ©pikselstock

Image credit: Adobe Stock / ©pikselstock

Bausch + Lomb and Glaucoma Research Foundation have partnered to launch the second annual Faces of Glaucoma campaign. The campaign, aimed at highlighting diverse patient stories and raising awareness of glaucoma will take place throughout Glaucoma Awareness Month in January.

Throughout the month, Bausch + Lomb and GRF will spotlight educational resources and share stories of individuals and families living with glaucoma to raise awareness and encourage proactive eye health management. In addition, B+L will support a fundraising campaign, matching up to $20,000, which will support GRF research on a potential cure for glaucoma.

The search for a cure for glaucoma is led by Catalyst for a Cure, Glaucoma Research Foundation’s flagship research program. According to the organization, the Catalyst for a Cure initiative brings together neuroscientists and glaucoma specialists to study glaucoma, find better treatments, and accelerate progress toward vision restoration and a cure.

Materials from the campaign are available online and include information on lifestyle tips for glaucoma patients as well as what can be done to prevent glaucoma.

Andrew Stewart, president of global pharmaceuticals and international consumer, Bausch + Lomb discussed the initiative in a press release from the company.

“It’s estimated that half of people with glaucoma don’t know that they have it, demonstrating a need for continuing education and awareness efforts,” said Stewart. “In collaboration with Glaucoma Research Foundation, we aim to encourage people to take an active role in understanding and managing their risk, starting with seeing an eye doctor.”

Early detection being key, the organizations state that glaucoma checkups should be conducted:

  • before age 40, every two to four years
  • from age 40 to age 54, every one to three years
  • from age 55 to 64, every one to two years
  • after age 65, every six to 12 months
References:
  1. Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge. Press Release. Published January 7, 2025. Accessed January 7, 2025.https://www.businesswire.com/news/home/20250107193963/en/Bausch-Lomb-and-Glaucoma-Research-Foundation-Launch-Second-Annual-%E2%80%9CFaces-of-Glaucoma%E2%80%9D-Campaign-and-Fundraising-Challenge

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
© 2025 MJH Life Sciences

All rights reserved.